References
- Galton D. A. G., Wiltshaw E., Szur L., Dacie J. V. The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukaemia. British Journal of Haematology 1961; 7: 73–98
- French Cooperative Group on Chronic Lymphocytic Leukaemia. Long term results of the CHOP regimen in stage C chronic lymphocytic leukaemia. British Journal of Haematology 1989; 73: 334–340
- Catovsky D., Fooks J., Richards S. for the MRC Working Party on Leukaemia in Adults Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. British Journal of Haematology 1989; 72: 141–149
- Bennett J. M. The use of ‘CHOP’ in the treatment of CLL. British Journal of Haematology 1990; 74: 546
- Catovsky D., Foa R. The Lymphoid Leukaemias. Butterworths, London 1990; 73–112
- Keating M. J., Hester J. P., McCredie K. B., Burgess M. A., Murphy W. K., Freireich E. J. Long-term results of CAP therapy in chronic lymphocytic leukemia. Leukemia and Lymphoma 1990; 2: 391–397
- Piro L. D., Carrera C. J., Beutler E., Carson D. A. 2-chloro-deoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 1988; 72: 1069–1073
- Keating M. J., Kantarjian H., O'Brien S., Koller C., Talpaz M., Schachner J., Childs C. C., Freireich E. J., McCredie K. B. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. Journal of Clinical Oncology 1991; 9: 44–49